We adjust by indication and severity, not body mass
GHK-Cu - typically around 12 mg per day subcutaneously
GLP-1 therapy works in significant part by weakening the body's normal appetite feedback, the homeostatic system that increases hunger as weight is lost
It can lead to dark urine as well as: dry mouth and lips thirst dizziness or weakness trouble swallowing dry food constipation fatigue Children, older adults, and people living with severe illnesses, such as cancer, are more prone to dehydration
The reconstitution technique is the same, but the concentration calculations produce very different numbers
Together they suppress appetite and improve glycemic control more strongly than either arm alone but that combined pull on the gut is also the reason someone who starts at a maintenance dose typically feels wretched